Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
antibody drug conjugates
Biotech
Fibrosis-focused Endeavor bags $132.5M series C
Endeavor BioMedicines is $132.5 million richer, courtesy of another nine-digit financing round that plows additional cash runway through 2026.
Max Bayer
Apr 24, 2024 7:30am
BMS-backed TORL grabs $158M to march army of ADCs through clinic
Apr 10, 2024 9:35am
Merck & Co. signs $208M deal for biotech to improve ADC safety
Apr 8, 2024 9:22am
Merck KGaA signs $1.4B biobuck ADC deal with Caris
Apr 4, 2024 8:25am
Prostate cancer ADC breaks FibroGen's clinical losing streak
Apr 3, 2024 10:55am
Ipsen joins ADC race via $900M biobuck deal with Sutro
Apr 2, 2024 7:26am